PTGS2 and colorectal carcinoma: In CRC, overexpression of COX-2 in CRC tissues correlates with poor prognosis (52), while inhibition of the COX activity by non-steroidal anti-inflammatory drugs (NSAIDs) results in protective effects for CRC (53–55).